01 2AbbVie Corporation
02 1Gowling WLG (Canada) LLP
01 12414680
02 12429998
03 12512315
01 3Dexamethasone
01 3Intravitreal injection
01 12021-07-03
02 12021-11-28
03 12024-01-07
Patent Expiration Date : 2021-11-28
Date Granted : 2012-01-17
Brand Name : OZURDEX
Patent Number : 2429998
Filing Date : 2001-11-28
Strength per Unit : 0.7 mg
Dosage Form : Intravitreal injection
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2021-11-28
Date Granted : 2012-01-17
Patent Expiration Date : 2021-07-03
Date Granted : 2007-09-18
Brand Name : OZURDEX
Patent Number : 2414680
Filing Date : 2001-07-03
Strength per Unit : 0.7 mg
Dosage Form : Intravitreal injection
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2021-07-03
Date Granted : 2007-09-18
Patent Expiration Date : 2024-01-07
Date Granted : 2008-12-30
Brand Name : OZURDEX
Patent Number : 2512315
Filing Date : 2004-01-07
Strength per Unit : 0.7 mg
Dosage Form : Intravitreal injection
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2024-01-07
Date Granted : 2008-12-30
LOOKING FOR A SUPPLIER?
